Leqvio (inclisiran) - Novartis
Serial Coronary Plaque Composition After Inclisiran Initiation Assessed by Automated CCTA: A Retrospective Pilot Study. (PubMed, Diagnostics (Basel)) - Sep 27, 2026 - " Patients initiating inclisiran showed temporal changes in attenuation-defined plaque composition. The uncontrolled design, incomplete acquisition data in the expanded cohort, and technical variability preclude causal or histologic interpretation." 
Journal • Retrospective data • Dyslipidemia
http://www.ncbi.nlm.nih.gov/pubmed/42793794
 
Daiji Miura; Hiroaki Matsumi; Junji Mochizuki; Kentaro Kawada; Masafumi Suzuki; Yoshiki Hata
 
Sep 27, 2026
 
Prev Next